ELIM BIOPHARMACEUTICALS INC has a total of 13 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), Hong Kong and Australia. Its main competitors in its focus markets biotechnology and pharmaceuticals are QUANTA BIOSCIENCES INC, EPICENTRE TECHNOLOGIES CORP and FUJIAN CHENXINKE BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Hong Kong | 3 | |
#3 | Australia | 2 | |
#4 | United States | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms | |
#3 | Fermentation | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Yilin | 12 |
#2 | Lu Xianbin | 2 |
#3 | Sun Lihyun | 2 |
#4 | Zhang Yi-Lin | 1 |
Publication | Filing date | Title |
---|---|---|
EP2971186A1 | ENRICHMENT AND NEXT GENERATION SEQUENCING OF TOTAL NUCLEIC ACID COMPRISING BOTH GENOMIC DNA AND cDNA | |
EP2925894A1 | Single-stranded polynucleotide amplification methods | |
AU2947201A | Novel plasmid dna vectors |